Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Change in Inventory (2019 - 2025)

Bioadaptives' Change in Inventory history spans 7 years, with the latest figure at $4654.0 for Q3 2025.

  • For Q3 2025, Change in Inventory changed N/A year-over-year to $4654.0; the TTM value through Sep 2025 reached $25113.0, up 78.11%, while the annual FY2023 figure was $6404.0, 55.17% up from the prior year.
  • Change in Inventory for Q3 2025 was $4654.0 at Bioadaptives, up from -$1010.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $21469.0 in Q1 2025 and bottomed at -$13279.0 in Q4 2021.
  • The 5-year median for Change in Inventory is $1744.0 (2023), against an average of $1920.5.
  • The largest YoY upside for Change in Inventory was 582.68% in 2021 against a maximum downside of 495.8% in 2021.
  • A 5-year view of Change in Inventory shows it stood at -$13279.0 in 2021, then soared by 155.55% to $7377.0 in 2022, then increased by 8.87% to $8031.0 in 2023, then crashed by 65.41% to $2778.0 in 2024, then soared by 67.53% to $4654.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Change in Inventory are $4654.0 (Q3 2025), -$1010.0 (Q2 2025), and $21469.0 (Q1 2025).